Publications

Show Filters

Searches all publications.

Search Fulltext

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-06-23
    E.g., 2018-06-23

Articles

12160 items
10:14 AM, May 24, 2018  |  BC Extra | Financial News

Melinta raises $110M in follow-on

Anti-infectives company Melinta Therapeutics Inc. (NASDAQ:MLNT) raised $110 million through the sale of 22 million shares at $5 in a follow-on underwritten by J.P. Morgan, Jefferies and Cantor Fitzgerald. The price is a 32% discount...
5:07 AM, May 24, 2018  |  BC Extra | Financial News

Pivotal closes China fund at $150M

Pivotal bioVenture Partners China closed its USD Fund I at $150 million to invest in Chinese biotechs with in-licensed portfolios. Pivotal China's Jimmy Wei told BioCentury the VC plans to raise another $50 million toward...
9:18 PM, May 23, 2018  |  BC Extra | Financial News

Scholar Rock shares rise after IPO

Scholar Rock Holding Corp. (NASDAQ:SRRK) gained $1.50 (11%) to $15.50 in its first day of trading Thursday after raising $75 million through the sale of 5.4 million shares at $14 in an IPO. Jefferies, Cowen,...
9:13 PM, May 23, 2018  |  BC Extra | Financial News

Kiniksa upsizes IPO, raises $152.6M

Kiniksa Pharmaceuticals Ltd. (NASDAQ:KNSA) gained $1.47 to $19.47 Thursday after raising $152.6 million through the sale of 8.5 million shares at $18 in an upsized IPO underwritten by Goldman Sachs, J.P. Morgan, JMP Securities and...
4:14 PM, May 23, 2018  |  BC Extra | Financial News

Aptinyx proposes $80M IPO

Neurology company Aptinyx Inc. (Evanston, Ill.) proposed to raise $80 million in an IPO on NASDAQ underwritten by J.P. Morgan, Cowen, Leerink and BMO Capital Markets. The company expects data in 1H19 from a pair of...
2:45 PM, May 23, 2018  |  BC Extra | Financial News

Gene, cell therapy fund-raising set to outpace 2017 total

Gene and cell therapy companies have raised $2.3 billion in equity in 2018 as of the end of last week, according to BioCentury’s BCIQ database. The figure is more than half of the $4.5 billion...
2:16 PM, May 23, 2018  |  BC Extra | Financial News

Kronos raises seed round, names Bischofberger CEO

Cancer company Kronos Bio Inc. (Cambridge, Mass.) raised $18 million in seed financing Wednesday and hired Norbert Bischofberger as president and CEO. Bischofberger was EVP of R&D and CSO of Gilead Sciences Inc. (NASDAQ:GILD) until...
12:55 PM, May 23, 2018  |  BC Extra | Financial News

Pfizer Ventures leads Strata's $26M series B

Strata Oncology Inc. (Ann Arbor, Mich.) raised $26 million in a series B round led by Pfizer Ventures. Fellow new investors Merck Global Health Innovation Fund, Deerfield Management and Renaissance Venture Capital Fund participated, as...
12:55 PM, May 23, 2018  |  BC Extra | Financial News

Coherus raises $75M in follow-on

Coherus BioSciences Inc. (NASDAQ:CHRS) raised $75 million through the sale of 5.2 million shares at $14.50 in a follow-on underwritten by J.P. Morgan, Citigroup, Mizuho, Baird, Maxim Group and H.C. Wainwright. The price is a 5%...
9:48 AM, May 23, 2018  |  BC Extra | Financial News

MyoKardia prices $184M follow-on

MyoKardia Inc. (NASDAQ:MYOK) raised $183.8 million late Tuesday through the sale of 3.8 million shares at $49 in a follow-on underwritten by J.P. Morgan, BofA Merrill Lynch, Credit Suisse and Wells Fargo. The price is...

Pages